Michael Thomas Heffernan Insider Trading $AKBA Akebia Therapeutics, Inc.
Get free email notifications about insider trading for Michael Thomas Heffernan.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Michael Thomas Heffernan. Michael Thomas Heffernan is Director in KERYX BIOPHARMACEUTICALS INC ($KERX) and Director in Ocata Therapeutics, Inc. ($ACTC) and Director in CORNERSTONE THERAPEUTICS INC ($CRTX) and Chairman, President and CEO in COLLEGIUM PHARMACEUTICAL, INC ($COLL) and Director in COLLEGIUM PHARMACEUTICAL, INC ($COLL) and in Akebia Therapeutics, Inc. ($AKBA) and Director in Akebia Therapeutics, Inc. ($AKBA) and Director in SYNLOGIC, INC. ($SYBX) and Director in Trevi Therapeutics, Inc. ($TRVI) and in Biohaven Pharmaceutical Holding Co Ltd. ($BHVN).
Michael Thomas Heffernan in Akebia Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Michael Thomas Heffernan:
Holdings: 34,886 shares
Current Value: $344,674
Latest Transaction: Jun 09 2020
$AKBA Market Capitalization: $177.33M
$AKBA Previous Close: $9.88
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Michael Thomas Heffernan in Akebia Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKBA, BHVN, COLL, CRTX, KERX, ACTC, SYBX, TRVI
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 09 2020 | AKBA | Akebia Therapeutic ... | Heffernan Michael Thomas | Option Exercise | A | 11.96 | 20,100 | 240,396 | 20,100 | ||
| Jun 09 2020 | AKBA | Akebia Therapeutic ... | Heffernan Michael Thomas | Grant | A | 0.00 | 13,700 | 0 | 34,886 | 21.2 K to 34.9 K (+64.67 %) | |
| Jun 10 2019 | AKBA | Akebia Therapeutic ... | Heffernan Michael Thomas | Option Exercise | A | 4.23 | 20,100 | 85,023 | 20,100 | ||
| Jun 10 2019 | AKBA | Akebia Therapeutic ... | Heffernan Michael Thomas | Grant | A | 0.00 | 13,700 | 0 | 21,186 | 7.5 K to 21.2 K (+183.01 %) | |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | Heffernan Michael Thomas | Director | Option Exercise | A | 8.94 | 25,000 | 223,500 | 25,000 | |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | Heffernan Michael Thomas | Director | Option Exercise | A | 10.05 | 11,229 | 112,851 | 11,229 | |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | Heffernan Michael Thomas | Director | Option Exercise | A | 17.53 | 11,229 | 196,844 | 11,229 | |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | Heffernan Michael Thomas | Director | Option Exercise | A | 16.17 | 18,716 | 302,638 | 18,716 | |
| Dec 13 2018 | AKBA | Akebia Therapeutic ... | Heffernan Michael Thomas | Director | Grant | A | 0.00 | 7,486 | 0 | 7,486 | 0 to 7.5 K |
Page: 1